pretomanid Treatment for Tuberculosis — Resistant TB Medicine Pretomanid Enters Regulatory Review Process in the United States NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has been accepted for review by the United States Food and Drug Administration (FDA). The application is for the […]Continue Reading ...
Credit: McGill University According to the World Health Organization, approximately 180,000 deaths every year are caused by burns, with the majority occurring in low- and middle-income countries. Upon arriving at the emergency room with a burn, the patient undergoes a clinical inspection to assess both the severity of the lesion in relation to the affected […]Continue Reading ...
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson’s disease. Credit: Wikipedia Scientists have gained clues into how a Parkinson’s disease treatment, called deep brain stimulation, helps tackle symptoms. The early-stage study, by researchers at Imperial College London, suggests the treatment boosts the number and strength of […]Continue Reading ...
Major depressive disorder is a debilitating illness that affects more than 350 million people around the world. The most common treatments for depression are Selective Serotonin Reuptake Inhibitors (SSRIs), drugs such as Prozac that increase serotonin levels in some regions of the brain. About half of the patients who take the pills, however, do not […]Continue Reading ...
Operators of wastewater treatment plants depend on reliable methods to monitor plant performance.Continue Reading ...
High magnification micrograph of Crohn’s disease. Biopsy of esophagus. H&E stain. Credit: Nephron/Wikipedia The largest study ever to look at why an expensive and commonly used group of drugs fails patients with Crohn’s disease has concluded that standardised drug doses are often too low. A UK wide collaboration led by the University of Exeter and […]Continue Reading ...
The products of wastewater treatment have been found to contain trace amounts of antibiotic resistant DNA. These products are often reintroduced to the environment and water supply, potentially resulting in the spread of antibiotic resistance. As such, researchers at the University of Southern California Viterbi School of Engineering have been studying the development of these […]Continue Reading ...
March 5, 2019 — The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting from sedation and […]Continue Reading ...
Treatment for Acne Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs […]Continue Reading ...
Men who receive anti-hormonal treatment after having their prostate removed are 80% more likely to suffer from depression than men who don’t receive this treatment. This leads researchers to suggest that patients receiving androgen deprivation therapy should be monitored for post-surgical depression. This is presented at the European Association of Urology congress in Barcelona. Increasingly […]Continue Reading ...
Mar 13 2019 A new risk model, easily accessible on a web interface, can predict the survival of non-metastatic prostate cancer patients, as well as the effect of different treatment approaches on survival. The modeling approach, developed by David Thurtle of the University of Cambridge, UK, and colleagues, is described this week in PLOS Medicine. […]Continue Reading ...
A two-week treatment course for adult patients with chronic Chagas disease showed, when compared to placebo, similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative (DNDi). Chagas disease affects an estimated […]Continue Reading ...
The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression. Image Credit: Grey_and / Shutterstock The drug brand named Spravato contains Esketamine as is manufactured by Janssen (14-2 in favour of the drug). It is claimed to lift the mood of […]Continue Reading ...
Credit: CC0 Public Domain For children undergoing immunotherapy – a promising treatment for peanut allergies – uncomfortable side effects can induce anxiety, perhaps to the point of skipping doses or dropping treatment entirely. But guiding young patients to the mindset that uncomfortable side effects are a sign that treatment is working can help reduce anxiety, […]Continue Reading ...
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI (Royal College of Surgeons Ireland), has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy. Based on aggregated clinical data analytics, the project will provide insights into […]Continue Reading ...
- Piece of puzzle unlocked in what drives alcohol addiction
- Researchers investigate whether Zika reservoirs are found in the Americas
- Compounds found in coffee may inhibit growth of prostate cancer
- Lab Innovations returns to the NEC on 30 & 31 October 2019
- How genes affect tobacco and alcohol use
- Plant cellulose bone implants are “viable” option to support new bone growth, study finds
- Older people living in retirement communities benefit from improved health
- UTSA professor helps train first responders to detect prescription opioid overdoses
- Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
- Smoking may limit body’s ability to fight dangerous form of skin cancer
- Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
- TGen and ABL sign agreement to distribute new TB test technology
- UCD researchers lead development of new urine test to detect prostate cancer
- Miniature brains that can move muscles, grown in the lab
- Servier and Oncodesign announce research and drug development partnership
- FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
- TB Medicine Pretomanid Enters Regulatory Review Process in the United States
- Breastfeeding can erase effects of prenatal violence for newborns
- Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
- Space worries – shingles affecting astronauts says NASA